/PRNewswire/ The "Phase I CRO Benchmarking (13th Ed.)" report has been added to ResearchAndMarkets.com s offering. We know many sponsor companies turn to.
Share this article
Share this article
ResearchAndMarkets.com s offering.
Clinical outsourcing needs and perceptions can vary quite a bit by company. The publisher understands the desire for a deeper dive regarding the small and emerging biopharma landscape.
This research will help small and emerging biopharma companies make more informed CRO selection decisions. These findings will also help CROs optimize operational and marketing strategies to better accommodate this segment. The degree of detail provided in this report - straight from small and emerging biopharma customers - on CRO awareness, familiarity, reported use, and preference along with perceived leadership, cost perceptions and CRO selection drivers offers a bird s eye view into this segment.